Which Weight Loss Method Keeps Weight Off Best? Comparing Lifestyle, Surgery, and Semaglutide
A systematic review of 29 RCTs finds lifestyle interventions rank highest for preventing weight regain, while semaglutide supports sustained loss during use but weight returns after stopping.
Quick Facts
What This Study Found
Lifestyle interventions ranked highest for preventing recurrent weight gain; semaglutide supports sustained loss during treatment but weight regain occurs after discontinuation; bariatric surgery provides the largest initial loss.
Key Numbers
How They Did This
Systematic review and network meta-analysis of 29 RCTs with literature search through March 2025.
Why This Research Matters
The biggest challenge in obesity treatment isn't losing weight — it's keeping it off. This analysis directly compares the long-term weight maintenance of the three major treatment approaches.
The Bigger Picture
This challenges the narrative that semaglutide is a permanent solution for obesity — without ongoing use, weight returns. The finding that lifestyle changes best prevent regain underscores the importance of behavioral foundations.
What This Study Doesn't Tell Us
Heterogeneous trial designs and follow-up durations; lifestyle intervention intensity varies widely; semaglutide discontinuation data limited; surgical techniques differ across studies.
Questions This Raises
- ?Is lifelong semaglutide use the only way to maintain its weight loss benefits?
- ?Could combining semaglutide with intensive lifestyle intervention optimize long-term weight maintenance?
Trust & Context
- Key Stat:
- 29 RCTs compared Network meta-analysis ranking lifestyle, semaglutide, and surgery for weight maintenance
- Evidence Grade:
- Systematic review and network meta-analysis of RCTs — highest level of evidence synthesis for comparative effectiveness.
- Study Age:
- Published in 2026 with evidence through March 2025, providing the most current comparative weight maintenance data.
- Original Title:
- Recurrent Weight Gain after Weight Loss Induced by Lifestyle Intervention, Metabolic and Bariatric Surgery, or Semaglutide in Adults with Obesity: A Systematic Review of Randomized Controlled Trials.
- Published In:
- Obesity surgery, 36(2), 792-803 (2026)
- Authors:
- Chen, Huixian, Guo, Xiaojing(2), Long, Tianxue, Li, Mingzi
- Database ID:
- RPEP-14976
Evidence Hierarchy
Frequently Asked Questions
Do you gain weight back after stopping semaglutide?
This meta-analysis confirms that weight regain occurs after semaglutide discontinuation. The drug supports weight maintenance during use, but patients need ongoing treatment or strong lifestyle foundations to maintain results.
Which weight loss method is best long-term?
It depends on goals: bariatric surgery produces the most total weight loss, semaglutide maintains loss while you take it, and lifestyle interventions are best at preventing regain. A combined approach may be optimal.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14976APA
Chen, Huixian; Guo, Xiaojing; Long, Tianxue; Li, Mingzi. (2026). Recurrent Weight Gain after Weight Loss Induced by Lifestyle Intervention, Metabolic and Bariatric Surgery, or Semaglutide in Adults with Obesity: A Systematic Review of Randomized Controlled Trials.. Obesity surgery, 36(2), 792-803. https://doi.org/10.1007/s11695-025-08415-1
MLA
Chen, Huixian, et al. "Recurrent Weight Gain after Weight Loss Induced by Lifestyle Intervention, Metabolic and Bariatric Surgery, or Semaglutide in Adults with Obesity: A Systematic Review of Randomized Controlled Trials.." Obesity surgery, 2026. https://doi.org/10.1007/s11695-025-08415-1
RethinkPeptides
RethinkPeptides Research Database. "Recurrent Weight Gain after Weight Loss Induced by Lifestyle..." RPEP-14976. Retrieved from https://rethinkpeptides.com/research/chen-2026-recurrent-weight-gain-after
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.